About BioConsortia
BioConsortia is developing highly effective microbial consortia for increasing agricultural yields. Soil and plant-associated microbes interact with and supplement the functions encoded by the crop genome. Opportunities abound to exploit these plant-microbe interactions, but overwhelming complexity and the huge amount of genetic diversity have hindered the realization of these by conventional R&D methods. BioConsortia has developed a revolutionary Advanced Microbial Selection (AMS) process for crop trait enhancement that uses iterative rounds of plant phenotyping and selection to co-select for beneficial changes in the microbiome. Isolates are obtained from the microbiome of plants expressing the desired traits and are developed as consortia for application as a commercial seed treatment, drench, or granule product. We have a pipeline of products for increased fertilizer utilization, growth improvement, and other beneficial crop traits, such as abiotic tolerance and enhanced metabolite expression.
Company details
Funding
Total raised
$95M
Last stage
Series F
Investors
Founders
Marcus Meadows-Smith
Experienced executive in specialty chemicals and biologics; previously CEO of AgraQuest (acquired by Bayer CropScience for ~$425M) and Head of Biologics at Bayer CropScience.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.
